Conceptio › Archive › Europe PMC
Europe PMCopen access

Immunogenicity and safety of an investigational quadrivalent measles, mumps, rubella, and varicella vaccine in children aged 4-6 years: A phase II, randomized, multi-country trial

Habib MA et al.
Europe PMC · Papers · License: Open Access
Open Source ↗Direct PDF ↓
safety
Safety, Immunogenicity, Pediatric, Phase Ii, Quadrivalent Vaccine, Second Dose
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 253535
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.